Zimmer biomet holdings inc ZBH.US Overview Analysis
ZBH AI Analysis Overview
Keys for Bullish View
- Value≥4
- Dividend≥2
Analysis Conclusion
The stock has received the highest rating for its value, and its dividend score is solid. It's ideal for long-term position building. For optimal entry, check our trend or swing trading rating.
ZBH Current Performance
0.11%
Zimmer biomet holdings inc
0.38%
Avg of Sector
-0.07%
S&P500
Top 10 High Relevance to ZBH
- SYK Stryker corporationValue 3Trend 3Swing Trading 5Whale Interest 3Dividend 4See more
ZBH Profile
Zimmer Biomet Holdings, Inc. is a global medical technology company. Its segments include Americas, Europe, Middle East and Africa (EMEA), and Asia Pacific. The Company designs, manufactures and markets orthopedic reconstructive products; biologics, sports medicine, extremities and trauma (S.E.T.) products; craniomaxillofacial and thoracic (CMFT) products; surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. Its products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Its knee brands include the Persona Knee, NexGen Knee Implants, Vanguard Knee, and Oxford Partial Knee. Its hip brands include the Taperloc Hip System, Avenir Complete Hip System, Arcos Modular Hip System, and G7 Acetabular System. Its S.E.T. product category includes sports medicine, biologics, foot and ankle, among others.